Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EMJ Oncology 11.1 2023
December 2023
In our latest issue of EMJ Oncology, you will find a variety of peer-review articles on a range of topics, as well as exclusive interviews…
Read more
November 2020
EMJ Oncology 8.1 2020
EMJ Oncology shares an impressive collection of new and interesting research, alongside our independent review of European Society for Medical Oncology (ESMO) Virtual Congress 2020 with research and breaking news from the virtual event.
September 2020
EMJ Oncology 8 [Supplement 3] 2020
Patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) derive little benefit from standard therapies and have an extremely poor prognosis…
August 2020
EMJ Oncology 8 [Supplement 2] 2020
Cyclin-dependent kinase (CDK) 4/6 inhibitors in combination with endocrine therapy (ET) are considered the standard-of-care treatment for patients…
August 2020
EMJ Oncology 8 [Supplement 1] 2020
Up to 80% of patients with cancer are affected by chemotherapy-induced nausea and vomiting (CINV) if the appropriate preventive healthcare…
December 2019
EMJ Oncology 7 [Suppl 2] 2019
This Ferring-organised Meet-The-Expert symposium at the European Society of Medical Oncology (ESMO) 2019 meeting aimed to discuss new treatment…
November 2019
EMJ Oncology 7.1 2019
This edition of EMJ Oncology 7.1 offers to the readers a wide range of topics and papers in relation to cancer diagnosis and management…
May 2019
EMJ Oncology 7 [Suppl 1] 2019
This review covers the inherent difficulties in stratifying early-stage breast cancer patients with regard to risk of recurrence.
December 2018
EMJ Oncology 6 [ePrint] 2018
In this review of the 2018 ESMO congress, the breaking news from the event is highlighted, including a feature covering the presidential symposia…
Loading posts...
« Previous
1
…
3
4
5
6
7
Next »